Utility of albumin-adjusted calcium and calcium‒phosphorus difference in screening for primary hyperparathyroidism

Ataru Okumura, Tatsuya Bando, Ryosei Ashida, Mitsuhiro Kuno, Naoki Tamaki, Toshihiro Mizuguchi, Issei Uchida, Hiroshi Arima

Open source

DOI
10.1186/s12902-026-02223-z
Published
2026-04-24
Container
BMC Endocrine Disorders
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12902-026-02223-z,
  title = {Utility of albumin-adjusted calcium and calcium‒phosphorus difference in screening for primary hyperparathyroidism},
  author = {Ataru Okumura and Tatsuya Bando and Ryosei Ashida and Mitsuhiro Kuno and Naoki Tamaki and Toshihiro Mizuguchi and Issei Uchida and Hiroshi Arima},
  year = {2026},
  journal = {BMC Endocrine Disorders},
  doi = {10.1186/s12902-026-02223-z},
  url = {https://doi.org/10.1186/s12902-026-02223-z}
}

RIS

TY  - JOUR
TI  - Utility of albumin-adjusted calcium and calcium‒phosphorus difference in screening for primary hyperparathyroidism
AU  - Ataru Okumura
AU  - Tatsuya Bando
AU  - Ryosei Ashida
AU  - Mitsuhiro Kuno
AU  - Naoki Tamaki
AU  - Toshihiro Mizuguchi
AU  - Issei Uchida
AU  - Hiroshi Arima
PY  - 2026
JO  - BMC Endocrine Disorders
DO  - 10.1186/s12902-026-02223-z
UR  - https://doi.org/10.1186/s12902-026-02223-z
ER  - 

APA

Okumura, A., Bando, T., Ashida, R., Kuno, M., Tamaki, N., Mizuguchi, T., Uchida, I., & Arima, H. (2026). Utility of albumin-adjusted calcium and calcium‒phosphorus difference in screening for primary hyperparathyroidism. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-026-02223-z

Source records